Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,016 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $193.48 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $188.01 | 4 | $0 (2024) |
| Novo Nordisk Inc | $165.44 | 10 | $0 (2024) |
| ITI, Inc. | $124.95 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $123.16 | 1 | $0 (2021) |
| Axsome Therapeutics, Inc. | $115.25 | 1 | $0 (2023) |
| SK Life Science, Inc. | $26.50 | 1 | $0 (2021) |
| SI-BONE, INC. | $22.33 | 1 | $0 (2024) |
| PFIZER INC. | $16.34 | 1 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $14.90 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $218.77 | 6 | Lilly USA, LLC ($121.81) |
| 2023 | $354.13 | 7 | AstraZeneca Pharmaceuticals LP ($145.76) |
| 2022 | $278.93 | 11 | Novo Nordisk Inc ($127.95) |
| 2021 | $164.56 | 3 | GlaxoSmithKline, LLC. ($123.16) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Obesity | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $22.33 | General |
| 09/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: PAIN | ||||||
| 03/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $121.81 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Diabetes | ||||||
| 09/15/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Rare Disease | ||||||
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $115.76 | General |
| Category: Rare Disease | ||||||
| 06/12/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Diabetes | ||||||
| 04/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $42.71 | General |
| Category: Diabetes | ||||||
| 03/16/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | Cash or cash equivalent | $115.25 | General |
| Category: Neurology | ||||||
| 02/09/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Obesity | ||||||
| 11/16/2022 | Novo Nordisk Inc | Rybelsus (Drug), Tresiba, Ozempic | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Diabetes | ||||||
| 10/21/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Obesity | ||||||
| 10/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Cardio-renal | ||||||
| 09/07/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: PSYCHIATRY | ||||||
| 08/19/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Obesity | ||||||
| 06/10/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Obesity | ||||||
| 03/08/2022 | Novo Nordisk Inc | Rybelsus (Drug), Tresiba, Ozempic | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Diabetes | ||||||
| 03/03/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Obesity | ||||||
| 03/03/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Obesity | ||||||
| 03/03/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $1.82 | General |
| Category: Obesity | ||||||
| 02/17/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 201 | 331 | $76,203 | $10,705 |
| 2022 | 2 | 134 | 194 | $43,510 | $6,029 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 88 | 170 | $38,678 | $5,788 | 15.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 52 | $16,870 | $2,746 | 16.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 53 | 70 | $15,470 | $1,135 | 7.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Facility | 2023 | 11 | 28 | $2,688 | $719.60 | 26.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 11 | 11 | $2,497 | $316.80 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 74 | 106 | $24,062 | $4,051 | 16.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 60 | 88 | $19,448 | $1,977 | 10.2% |
About Charlotte Barrett
Charlotte Barrett is a Family healthcare provider based in Sallisaw, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2021. The National Provider Identifier (NPI) number assigned to this provider is 1194300525.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Charlotte Barrett has received a total of $1,016 in payments from pharmaceutical and medical device companies, with $218.77 received in 2024. These payments were reported across 27 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,016).
As a Medicare-enrolled provider, Barrett has provided services to 335 Medicare beneficiaries, totaling 525 services with total Medicare billing of $16,733. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Sallisaw, OK
- Active Since 03/17/2021
- Last Updated 10/01/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1194300525
Products in Payments
- MOUNJARO (Drug) $164.52
- ANDEXXA (Biological) $145.76
- CAPLYTA (Drug) $124.95
- TRELEGY ELLIPTA (Drug) $123.16
- Sunosi (Drug) $115.25
- Saxenda (Drug) $87.83
- LOKELMA (Drug) $42.25
- Rybelsus (Drug) $40.12
- Wegovy (Drug) $37.49
- NURTEC ODT (Drug) $31.24
- TRULICITY (Drug) $28.96
- XCOPRI (Drug) $26.50
- ENTRESTO (Drug) $13.80
- Kerendia (Drug) $12.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Sallisaw
Mrs. Audra O'dell, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $2,838
Amy Brown, Aprn-Cnp, APRN-CNP
Family — Payments: $2,336
Danna Orendorff, Arnp, ARNP
Family — Payments: $1,126
Mrs. Rebel Smith, Arnp, ARNP
Family — Payments: $596.52
Stefanie Labs
Family — Payments: $249.92
Alexandria Crocker, Dnp, DNP
Family — Payments: $195.51